Artiva Biotherapeutics, Inc.’s ARTV share price has dipped by 7.23%, which has investors questioning if this is right time to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

ARTV stock opened at $3.64 on Wednesday. The firm has a 50 day moving average of $4.84 and a 200-day moving average of $9.33. Artiva Biotherapeutics has a 12 month low of $3.37 and a 12 month high ...

Cantor Fitzgerald analyst Joshua Schimmer maintained a Buy rating on Artiva Biotherapeutics, Inc. (ARTV – Research Report) on March 25 and set ...

Artiva Biotherapeutics (ARTV) announced the appointment of Subhashis Banerjee as chief medical officer. Banerjee was most recently disease area ...

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV – Free Report) – Stock analysts at HC Wainwright increased their Q1 2025 earnings per share estimates for Artiva Biotherapeutics in a research note ...

Members of the Artiva management team will also be available to participate in invest SAN DIEGO, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage ...